administrator

FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal

FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal

Online Controlled Substances Summits

FDA hosted its fourth summit on June 8, 2023, as an integral part of FDA’s overall efforts to protect the…

Nana Barseghian, M.D. – 708009 – 04/28/2025

Clinical Investigator

Umovy may be harmful due to hidden drug ingredients

The Food and Drug Administration is advising consumers not to purchase or use Umovy, a product promoted and sold for…

Unavy may be harmful due to hidden drug ingredients

The Food and Drug Administration is advising consumers not to purchase or use Unavy, a product promoted and sold for…

Amoxicillin Clavulanate – Oral products

Amoxicillin Clavulanate – Oral Products

Clorox mulls sourcing changes to offset $100M tariff hit

The approach differs from its peer P&G, which is delaying supply chain changes until there is greater certainty. 

Crocs yanks guidance, citing trade uncertainty

The company recently joined with other footwear brands to urge the Trump administration to exempt the category from tariffs.

dolotrex may be harmful due to hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use dolotrex, a product promoted and sold for…

‘Shared pain and gain:’ How shippers, carriers are forging relationship for the last mile

Consistent communication and collaborative performance evaluation are some of the keys to success, said experts from Dr. Squatch, Wayfair and…